GW Pharmaceuticals

Home/Tag: GW Pharmaceuticals

The Stash, Volume 51: Cannabis deal making continues to struggle as cash crunch intensifies

CANNABIS DEAL MAKING CONTINUES TO STRUGGLE AS CASH CRUNCH INTENSIFIES In our Dec. 18, 2019, Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. Capital market trends in 1H20 validate our thesis. Data from Viridian Capital Advisors shows that [...]

2020-07-15T19:08:41+00:00July 8th, 2020|

The Stash, Volume 43: Cannabis 2.0 is here and COVID-19 is accelerating the transition

CANNABIS 2.0 IS HERE AND COVID-19 IS ACCELERATING THE TRANSITION Market share gains for marijuana products like edibles and vapor pens in Canada suggest that the transition from Cannabis 1.0 to Cannabis 2.0 is happening at a rapid pace, with stay-at-home restrictions imposed due to COVID-19 acting as an additional catalyst. The launch of cannabis products [...]

2020-07-15T19:12:30+00:00May 13th, 2020|

The Stash, Volume 41: The two stocks best positioned to benefit from growing OK and OR cannabis markets

THE TWO STOCKS BEST POSITIONED TO BENEFIT FROM GROWING OK AND OR CANNABIS MARKETS In our Stash report last week, we discussed why Oklahoma (OK) and Oregon (OR) are well-positioned to benefit from cannabis’ essential industry status. This week, we highlight the two companies that are in a strong position in these markets and should be [...]

2020-07-15T19:13:35+00:00April 29th, 2020|

The Stash, Volume 39: COVID-19 is a Net Positive for Cannabis. Here’s why.

COVID-19 IS A NET POSITIVE FOR CANNABIS. HERE’S WHY. COVID-19’s impact on the cannabis industry is more positive than negative. While COVID-19 is a net negative for most industries, cannabis is among those where the net impact is positive. There are three reasons that bring us to this conclusion: 1) emergence of cannabis as an essential/staple, [...]

2020-04-15T19:48:06+00:00April 15th, 2020|

The Stash, Volume 30: Innovative Industrial Properties = High Dividend Yield + Strong Earnings Growth

INNOVATIVE INDUSTRIAL PROPERTIES (IIPR) = HIGH DIVIDEND YIELD + STRONG EARNINGS GROWTH Innovative Industrial Properties (IIPR) – the leading cannabis-focused real estate investment trust (REIT) – is one of the best cannabis names for investors to evaluate. IIPR focuses on the acquisition, ownership, and management of specialized industrial properties leased to experienced, state-licensed operators for their [...]

2020-03-30T14:02:15+00:00February 12th, 2020|

The Stash, Volume 29: Canna Finance – Set to Emerge from the Trough of Disillusionment?

CANNA FINANCE: SET TO EMERGE FROM THE TROUGH OF DISILLUSIONMENT? In our Dec. 18, 2019 Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. We expand on this subject this week by analyzing how cannabis companies went from being [...]

2020-03-30T14:02:42+00:00February 5th, 2020|

The Stash, Volume 27: Hemp – Driving Sustainable Growth in the Cannabis Industry

HEMP: DRIVING SUSTAINABILE GROWTH IN THE CANNABIS INDUSTRY Hemp’s sustainable properties are expected to drive the 34% CAGR in the global industrial hemp market to $26.6 billion over the next five years. Hemp commonly refers to the industrial/commercial use of the cannabis stalk and seed for textiles, food, paper, body care products, detergents, plastics, and building [...]

2020-03-30T14:03:56+00:00January 22nd, 2020|
Go to Top